SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891618-02-002856
Filing Date
2002-06-18
Accepted
2002-06-18 16:32:02
Documents
3
Period of Report
2002-06-17
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f82468e8vk.htm 8-K 11023
3 EXHIBIT 99.1 f82468exv99w1.txt EX-99.1 4447
4 EXHIBIT 99.2 f82468exv99w2.txt EX-99.2 4639
  Complete submission text file 0000891618-02-002856.txt   21898
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22570 | Film No.: 02681609
SIC: 2833 Medicinal Chemicals & Botanical Products